Prevention of ventricular arrhythmia complicating acute myocardial infarction by local cardiac denervation

International Journal of Cardiology
Jugang ChenJingjie Li

Abstract

Augmentation of sympathetic nerve activity after acute myocardial infarction (AMI) contributes to fatal arrhythmia. In this study, we investigated whether local ablation of the coronary sinus (CS) and great cardiac vein (GCV) peripheral nerves could reduce ventricular arrhythmias (VA) in a canine AMI model. Twenty-one anesthetized dogs were randomly assigned into the sham-operated, MI and MI-ablation groups, respectively. The incidence and duration of VA were monitored among different groups. The ventricular effective refractory period (ERP), the ERP dispersion and the ventricular fibrillation threshold (VFT) were measured during the experiments. Norepinephrine (NE) levels in CS blood and cardiac tissue were also detected in this study. The incidence and duration of VA in MI-ablation group were significantly reduced as compared to the MI dogs (p<0.05). Furthermore, local cardiac denervation drastically prolonged the ventricular ERP in the ischemia area, decreased the ERP dispersion, and reduced NE levels in CS blood (P<0.05). VFT also showed an increased trend in the AMI-ablation group. The results of this study indicate that, in the canine AMI model, local ablation of CS and GCV peripheral nerves reduces VA occurrence and impr...Continue Reading

References

Dec 1, 1991·European Heart Journal·A SchömigG Richardt
Jul 1, 1988·Journal of the American College of Cardiology·G S Francis
Jan 1, 1983·The American Journal of Cardiology·D A RichardsJ B Uther
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Apr 14, 2000·Circulation Research·J M CaoP S Chen
Apr 3, 2001·Cardiovascular Research·F L Burton, S M Cobbe
Jan 17, 2002·The New England Journal of Medicine·H V HuikuriR J Myerburg
Jul 2, 2003·Circulation·Miguel ValderrábanoShien-Fong Lin
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Siew Yen HoAnton E Becker
Sep 3, 2005·The Journal of Clinical Investigation·Michael Rubart, Douglas P Zipes
Nov 9, 2005·International Journal of Cardiology·Jose P S HenriquesFelix Zijlstra
May 7, 2009·JAMA : the Journal of the American Medical Association·Rajendra H MehtaUNKNOWN APEX AMI Investigators
Feb 23, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Heidi L LujanStephen E DiCarlo
Mar 4, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Inga SaburkinaDainius H Pauza
Jan 7, 2011·Pacing and Clinical Electrophysiology : PACE·Lin Jia-FengYang Peng-Lin
Dec 12, 2012·The American Journal of Cardiology·Daisaku NakataniUNKNOWN Osaka Acute Coronary Insufficiency Study (OACIS) Investigators
Jul 16, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Dominik LinzHans-Ruprecht Neuberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.